Predictors of coronary artery injury after orbital atherectomy as assessed by optical coherence tomography.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 03 10 2022
accepted: 13 03 2023
medline: 12 6 2023
pubmed: 8 4 2023
entrez: 7 4 2023
Statut: ppublish

Résumé

The association between the extent of the wire and device bias as assessed by optical coherence tomography (OCT) in the healthy portion of the vessel and the risk of coronary artery injury after orbital atherectomy (OA) has not been fully elucidated. Thus, purpose of this study is to investigate the association between pre-OA OCT findings and post-OA coronary artery injury by OCT. We enrolled 148 de novo lesions having calcified lesion required OA (max Ca angle > 90°) in 135 patients who underwent both pre- and post-OA OCT. In pre-OA OCT, OCT catheter contact angle and the presence or absences of guide-wire (GW) contact with the normal vessel intima were assessed. Also, in post-OA OCT, we assessed there was post-OA coronary artery injury (OA injury), defined as disappearance of both of intima and medial wall of normal vessel, or not. OA injury was found in 19 lesions (13%). Pre-PCI OCT catheter contact angle with the normal coronary artery was significantly larger (median 137°; inter quartile range [IQR] 113-169 vs. median 0°; IQR 0-0, P < 0.001) and more GW contact with the normal vessel was found (63% vs. 8%, P < 0.001). Pre-PCI OCT catheter contact angle > 92° and GW contact with the normal vessel intima were associated with post-OA vascular injury (Both: 92% (11/12), Either: 32% (8/25), Neither: 0% (0/111), P < 0.001). Pre-PCI OCT findings, such as catheter contact angle > 92° and guide-wire contact to the normal coronary artery, were associated with post-OA coronary artery injury.

Identifiants

pubmed: 37027104
doi: 10.1007/s10554-023-02837-7
pii: 10.1007/s10554-023-02837-7
pmc: PMC10250457
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1367-1374

Informations de copyright

© 2023. The Author(s).

Références

Cardiovasc Revasc Med. 2021 Jul;28:9-13
pubmed: 32888836
Circ Cardiovasc Interv. 2018 Oct;11(10):e007003
pubmed: 30354637
J Interv Cardiol. 2020 Nov 10;2020:1894389
pubmed: 33223973
Nat Rev Cardiol. 2022 Oct;19(10):684-703
pubmed: 35449407
JACC Cardiovasc Imaging. 2017 Aug;10(8):869-879
pubmed: 28797408
J Interv Cardiol. 2016 Aug;29(4):357-62
pubmed: 27358246
EuroIntervention. 2019 Jun 12;15(3):e279-e288
pubmed: 29769164
EuroIntervention. 2018 Apr 06;13(18):e2182-e2189
pubmed: 29400655
Catheter Cardiovasc Interv. 2012 Oct 1;80(4):621-5
pubmed: 21805585
EuroIntervention. 2019 Apr 20;14(17):1760-1767
pubmed: 29957595
JACC Cardiovasc Interv. 2014 May;7(5):510-8
pubmed: 24852804
JACC Cardiovasc Imaging. 2017 Aug;10(8):883-891
pubmed: 28797410
JACC Cardiovasc Interv. 2019 Mar 25;12(6):531-540
pubmed: 30898249
Int J Cardiovasc Imaging. 2021 Mar;37(3):803-812
pubmed: 33111175
Expert Rev Med Devices. 2017 Nov;14(11):867-879
pubmed: 28945162
Cardiovasc Revasc Med. 2022 Jul;40:123-131
pubmed: 35101372
Cardiovasc Interv Ther. 2020 Oct;35(4):361-370
pubmed: 31939066
J Am Coll Cardiol. 2014 May 13;63(18):1845-54
pubmed: 24561145
Cardiovasc Interv Ther. 2020 Jan;35(1):13-18
pubmed: 31602597
Catheter Cardiovasc Interv. 2021 Nov 1;98(5):884-892
pubmed: 33325587
Catheter Cardiovasc Interv. 2015 Nov 15;86(6):1024-32
pubmed: 25964009

Auteurs

Tetsumin Lee (T)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan. ltetsumin@gmail.com.

Takashi Ashikaga (T)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Toshihiro Nozato (T)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Masakazu Kaneko (M)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Ryoichi Miyazaki (R)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Shinichiro Okata (S)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Masashi Nagase (M)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Tomoki Horie (T)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Mao Terui (M)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Tetsuya Kishigami (T)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Yasutoshi Nagata (Y)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Toru Misawa (T)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Yuta Taomoto (Y)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Daigo Kachi (D)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Michihito Naito (M)

Department of Cardiology, Japanese Red Cross Musashino Hospital, 1-26-1 Kyonancho, Musashinoshi, Tokyo, Tokyo, Japan.

Taishi Yonetsu (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Tetsuo Sasano (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH